Search results for "Molecular-Weight"

showing 10 items of 72 documents

Tunable radical scavenging activity of carbon nanotubes through sonication

2016

Abstract Carbon nanotubes (CNTs) having controlled radical scavenging activity have been achieved tuning the content of their lattice defects induced by an ultra-sound (us) treatment. The reactivity of CNTs, subjected to ultra-sonication for different time intervals, toward 1,1-diphenyl-2-pycryl (DPPH) and hydroxyl (•OH) radicals has been estimated and related to defect concentration, evaluated through Raman spectrometry. The radical scavenging efficiency of ultra-sound treated CNTs (us-CNTs) increases with increasing the content of the structural defects, suggesting that the defect resulting from us treatment can be capitalized to obtain an amplified and controlled radical scavenging activ…

Materials scienceSonicationRadical02 engineering and technologyCarbon nanotube010402 general chemistry01 natural scienceslaw.inventionsymbols.namesakechemistry.chemical_compoundDISPERSIONlawANTIOXIDANTCOMPOSITESOrganic chemistryMOLECULAR-WEIGHT POLYETHYLENEGeneral Materials ScienceReactivity (chemistry)ScavengingUltra-high-molecular-weight polyethyleneNanocompositeChemistry (all)General ChemistrySettore CHIM/06 - Chimica Organica021001 nanoscience & nanotechnologyNANOCOMPOSITES0104 chemical sciencesSettore ING-IND/22 - Scienza E Tecnologia Dei MaterialichemistryChemical engineeringsymbolsFUNCTIONALIZATION0210 nano-technologyRaman spectroscopy
researchProduct

Thrombolytic therapy for submassive pulmonary embolism.

2012

Approximately 10% of all patients with acute pulmonary embolism (PE) die within the first three months after diagnosis. However, PE is not universally life-threatening, but covers a wide spectrum of clinical severity and death risk. Thrombolytic treatment is indicated patients with acute massive PE who are at high risk for early death, i.e. those patients who present with arterial hypotension and shock. On the other hand, low molecular-weight heparin or fondaparinux is adequate treatment for most normotensive patients with PE. Recombinant tissue plasminogen activator, given as 100 mg infusion over 2 h, is the treatment of choice for patients with PE, although older regimens using urokinase …

medicine.medical_specialtymedicine.medical_treatmentStreptokinaseVentricular Dysfunction RightClinical Biochemistry030204 cardiovascular system & hematologyFondaparinuxlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialFibrinolytic AgentslawPolysaccharidesRisk FactorsInternal medicinemedicineHumansStreptokinaseThrombolytic Therapy030212 general & internal medicineIntensive care medicineUrokinaseClinical Trials as Topicbusiness.industryHeparinThrombolysisHeparin Low-Molecular-Weightmedicine.diseaseUrokinase-Type Plasminogen ActivatorTroponin3. Good healthPulmonary embolismRadiographyOncologyFondaparinuxTissue Plasminogen ActivatorAcute DiseaseCardiologybusinessPulmonary EmbolismBiomarkersmedicine.drugCohort studyBest practiceresearch. Clinical haematology
researchProduct

Multi-functional hindered amine light stabilizers-functionalized carbon nanotubes for advanced ultra-high molecular weight Polyethylene-based nanocom…

2015

Hindered Amine Light Stabilizer (HAS) molecules have been covalently linked on the outer surface of multi-walled carbon nanotubes (CNTs), and the so-obtained multi-functional fillers (HAS-f-CNTs) have been compounded with Ultra High Molecular Weight Polyethylene (UHMWPE) to get composite films. The success of the grafting reaction of the HAS molecules has been confirmed through spectroscopic and thermo-gravimetric analyses. Morphological analyses reveal a segregated microstructure, in which CNT-rich channels surround the polymer domains. This morphology results in improved mechanical properties and appreciable electrical conductive features. More importantly, the addition of only 1 wt.% of …

Polymer-matrix composites (PMCs)B. Rheological propertiePhoto-oxidative resistanceMaterials scienceB. Mechanical propertieComposite numberCeramics and CompositeCarbon nanotubeNano-structureIndustrial and Manufacturing EngineeringA. Nano-structures; A. Polymer-matrix composites (PMCs); B. Mechanical properties; B. Rheological properties; Photo-oxidative resistance; Ceramics and Composites; Mechanics of Materials; Mechanical Engineering; Industrial and Manufacturing Engineeringlaw.inventionchemistry.chemical_compoundA. Polymer-matrix composites (PMCs)lawA. Nano-structuresRheological propertieMechanics of MaterialComposite materialUltra-high-molecular-weight polyethylenechemistry.chemical_classificationB. Mechanical propertiesNanocompositeHindered amine light stabilizersA. Nano-structures; A. Polymer-matrix composites (PMCs); B. Mechanical properties; B. Rheological properties; Photo-oxidative resistance; Ceramics and Composites; Mechanics of Materials; Industrial and Manufacturing Engineering; Mechanical EngineeringMechanical EngineeringPolymerMicrostructureB. Rheological propertieschemistryMechanics of MaterialsA. Nano-structureCeramics and CompositesMechanical propertieStabilizer (chemistry)
researchProduct

Incidence of venous thromboembolism and use of anticoagulation in hematological malignancies: Critical review of the literature.

2018

Venous Thromboembolism (VTE) frequently complicates the course of hematologic malignancies (HM) and its incidence is similar to that observed in high-risk solid tumors. Despite that, pharmacologic prophylaxis and treatment of VTE in patients with HM is challenging, mainly because a severe thrombocytopenia frequently complicates the course of treatments or may be present since diagnosis, thus increasing the risk of bleeding. Therefore, in this setting, safe and effective methods of VTE prophylaxis and treatment have not been well defined and hematologists generally refer to guidelines produced for cancer patients that give indications on anticoagulation in patients with thrombocytopenia. In …

medicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentvenous thromboembolismLow molecular weight heparinHemorrhage030204 cardiovascular system & hematologyVte prophylaxis03 medical and health sciences0302 clinical medicineAntithromboticmedicineAnimalsHumanscardiovascular diseasesIntensive care medicineChemotherapybusiness.industryIncidence (epidemiology)IncidenceCancerAnticoagulantsHematologyVenous ThromboembolismHeparin Low-Molecular-Weightmedicine.diseaseThrombocytopeniaSevere thrombocytopeniaOncology030220 oncology & carcinogenesisHematologic NeoplasmsbusinessVenous thromboembolismCritical reviews in oncology/hematology
researchProduct

Nonadherence in outpatient thrombosis prophylaxis with low molecular weight heparins after major orthopaedic surgery

2010

Background: According to some current guidelines, extended thromboprophylaxis after hip and knee arthroplasties is recommended. Outpatient prophylaxis with low molecular weight heparins (LMWH) is an important part of this prophylaxis, although the rates of adherence to these regimens is not known. Questions/purposes: We determined (1) the degree of nonadherence (NA) of patients with LMWH outpatient prophylaxis, and (2) whether specific independent factors explain NA. Methods: NA was determined by syringe count and by indirect and direct questions to patients. We defined six different NA indicators. To identify factors explaining LMWH NA, we used three different logistic regression models. R…

musculoskeletal diseasesMaleQuestionnairesmedicine.medical_specialtyHealth Knowledge Attitudes PracticeTime Factorsmedicine.drug_classmedicine.medical_treatmentArthroplasty Replacement HipLow molecular weight heparinRisk AssessmentInjectionsMedication AdherenceAmbulatory careFibrinolytic AgentsClinical ResearchRisk FactorsInternal medicineSurveys and QuestionnairesGermanyAmbulatory CareMedicineHumansOrthopedics and Sports Medicine/dk/atira/pure/core/keywords/559092180Arthroplasty Replacement KneeAgedbusiness.industryAnticoagulantHealth sciencesThrombosisGeneral MedicineHeparinHeparin Low-Molecular-Weightmedicine.diseaseThrombosisArthroplastySurgeryTelephoneLogistic ModelsTreatment OutcomeOrthopedic surgerySurgeryFemalebusinessFibrinolytic agentmedicine.drug
researchProduct

Determination of molecular weights and Stokes' radii of non-denatured proteins by polyacrylamide gradient gel electrophoresis 3. Estimation of the up…

1985

Studying the separation behavior of various native carbonic anhydrase isozymes from mammalian erythrocytes we found that the migration of these enzymes differs from that of the marker proteins commonly used in gradient gel electrophoresis. In alkaline buffer systems the enzymes from human, bovine, rabbit, and canine erythrocytes start to migrate with a size apparently 6 to 12 times larger than their monomeric size, then gradually lose in apparent size and finally end up in a size equivalent to their monomeric mol mass. We determined the monomeric mol mass of the various carbonic anhydrase forms to be 23 000 to 39 000 (g/mol). These values are in accordance with different data in the literat…

Gel electrophoresischemistry.chemical_classificationChromatographyMolecular massbiologyChemistryClinical BiochemistryPolyacrylamideBiochemistryIsozymeAnalytical Chemistrychemistry.chemical_compoundEnzymeMolecular-weight size markerCarbonic anhydraseMolebiology.proteinElectrophoresis
researchProduct

Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normali…

2012

Subtherapeutic international normalized ratio (INR) is frequently encountered in clinical practice, and patients with high-risk atrial fibrillation (AF) and with mechanical heart valve (MHV) with inadequate anticoagulation may be exposed to an increased risk of thromboembolic events (TE). However, there are no prospective data evaluating this risk. Consecutive patients with a history of stable anticoagulation, but with a subtherapeutic INR, were prospectively included. Data on use and dose of low-molecular weight heparin (LMWH) bridging therapy were collected. The incidence of objectively confirmed TE and of major bleeding events within 90 days after the index INR was assessed. Five hundred…

MaleRiskmedicine.medical_specialtyPopulationvenous thromboembolismHemorrhageComorbidityThrombophiliaFollow-Up StudiePostoperative ComplicationsInternal medicineThromboembolismAtrial FibrillationmedicineHumansThrombophiliaProspective StudiesInternational Normalized RatioeducationProspective cohort studyAgedAged 80 and overHeart Valve Prosthesis Implantationeducation.field_of_studybusiness.industryIncidence (epidemiology)IncidenceMedicine (all)WarfarinAnticoagulantAnticoagulantsAtrial fibrillationHematologyHeparin Low-Molecular-WeightMiddle Agedmedicine.diseaseConfidence intervalSurgeryProspective StudieHeart Valve ProsthesiHeart Valve ProsthesisFemalePostoperative ComplicationWarfarinbusinessCohort studymedicine.drugFollow-Up StudiesHuman
researchProduct

Heparin in COVID-19 patients is associated with reduced in-hospital mortality: the multicentre Italian CORIST Study

2021

Abstract Introduction A hypercoagulable condition was described in patients with coronavirus disease 2019 (COVID-19) and proposed as a possible pathogenic mechanism contributing to disease progression and lethality. Aim We evaluated if in-hospital administration of heparin improved survival in a large cohort of Italian COVID-19 patients. Methods In a retrospective observational study, 2,574 unselected patients hospitalized in 30 clinical centers in Italy from February 19, 2020 to June 5, 2020 with laboratory-confirmed severe acute respiratory syndrome coronavirus-2 infection were analyzed. The primary endpoint in a time-to event analysis was in-hospital death, comparing patients who receive…

Malemedicine.medical_specialtySettore MED/17 - Malattie Infettivecoronavirusheparin030204 cardiovascular system & hematologyLower risklaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineClinical endpointmedicineHumansThrombophilia030212 general & internal medicineHospital MortalityBlood CoagulationSurvival analysisAgedRetrospective Studiestreatmentbusiness.industryHeparinMortality rateCOVID-19mortalityLow-Molecular-WeightAnticoagulantsCOVID-19Retrospective cohort studyHeparinHematologyHeparin Low-Molecular-WeightMiddle AgedmortalitySurvival AnalysisCOVID-19 Drug Treatmentcoagulation activationcoronaviruItalytreatmentsPropensity score matchingcoagulation activation; coronavirus; COVID-19; heparin; mortality; treatmentsFemalecoagulation activation; coronavirus; COVID-19; heparin; mortality; treatments; Aged; Anticoagulants; Blood Coagulation; COVID-19; Female; Heparin; Heparin Low-Molecular-Weight; Hospital Mortality; Humans; Italy; Male; Middle Aged; Retrospective Studies; Survival Analysis; Thrombophiliabusinessmedicine.drug
researchProduct

Multifunctional Poly(ethylene glycol)s

2011

In the rapidly evolving multidisciplinary field of polymer therapeutics, tailored polymer structures represent the key constituent to explore and harvest the potential of bioactive macromolecular hybrid structures. In light of the recent developments for anticancer drug conjugates, multifunctional polymers are becoming ever more relevant as drug carriers. However, the potentially best suited polymer, poly(ethylene glycol) (PEG), is unfavorable owing to its limited functionality. Therefore, multifunctional linear copolymers (mf-PEGs) based on ethylene oxide (EO) and appropriate epoxide comonomers are attracting increased attention. Precisely engineered via living anionic polymerization and d…

LymphomapolyethersNanotechnologyAntineoplastic AgentsPolyethylene glycolMolecular-WeightCatalysisPolyethylene Glycolschemistry.chemical_compoundepoxidesCopolymerOrganic chemistryAnimalsLiving anionic polymerizationchemistry.chemical_classificationWeight Hyperbranched PolyglycerolsDrug CarriersDrug-Delivery SystemsEthylene oxidepoly(ethylene glycol)Ethylene-OxideGene Transfer TechniquesPolymer TherapeuticsGeneral ChemistryPolymermultivalencybioconjugatesPendant Amino-GroupsPolyethylene-GlycolchemistryPolymerizationAnionic Peg DerivativesDoxorubicinBlock-CopolymersCisplatinIn-VivoDrug carrierPeptidesEthylene glycol
researchProduct

Multiple voltage‐gradient gel electrophoresis system

2001

A new device, based on the principle of voltage-gradient gel electrophoresis, was developed in order to enhance differentiation of the distance across the range of molecular masses in the electrophoretic fractionation of nucleic acids in an agarose matrix. The apparatus has a series of modular parallel plates, placed slantwise to allow reiteration of the voltage gradient effect along the gel. This subjects DNA fragments of variable length to differential runnings according to their original position in the gel. Both the number of slantwise plates and the distance between them can be changed to modify operating performance. Our system allows better fractionations as compared to conventional …

Gel electrophoresisTwo-dimensional gel electrophoresisGel electrophoresis of nucleic acidsDifference gel electrophoresisClinical BiochemistryAnalytical chemistryBiochemistryAnalytical Chemistrychemistry.chemical_compoundchemistryElectrochromatographyMolecular-weight size markerPulsed-field gel electrophoresisAgaroseELECTROPHORESIS
researchProduct